drugset / Trial / NCT07403487
Phase II Trial of RC1416 Injection in Asthma
RandomizedParallel-groupTriple-blindTreatment
Summary
This study is a phase II study of RC1416 in subjects with severe uncontrolled asthma. The purpose of the study is to evaluate efficacy and safety of RC1416 in subjects with severe uncontrolled asthma.
Timeline
- Start
- 2026-03-10
- Primary completion
- 2027-10-25
- Completion
- 2028-02-28
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | RC1416 | Protein / enzyme biologic | — | Subcutaneous |